Stay updated on Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoChange DetectedThe webpage has been updated to include new results and definitions related to the clinical study of pembrolizumab treatment in patients with acral lentiginous melanoma, while previous results and definitions have been removed.SummaryDifference7%
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study criteria for a clinical trial on acral lentiginous melanoma and the addition of a new revision number.SummaryDifference44%
- Check29 days agoChange DetectedThe web page has been updated from version v2.14.3 to v2.14.4.SummaryDifference0.1%
- Check59 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.